HMBT Insider Trading Activity and SEC Form 4 Filings
HMBT insider trading summary
No open-market insider purchases or sales of Hemobiotech Inc (HMBT) have been reported on SEC Form 4 in the past 12 months.
Latest HMBT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 21, 2005 | Mark J Rosenblum | Chief Financial Officer | Buy | $3K (2,000 @ $1.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.